NCT02801448View on ClinicalTrials.gov

Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Interventions
DRUG

sulforaphane

sulforaphane-containing broccoli sprout extracts

DRUG

Placebo

Maltodextrine-based placebo without sulforaphane

All Listed Sponsors
lead

Anders Rosengren, MD PhD

OTHER

NCT02801448 - Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter